CREATION OF A CONSTITUTIVELY ACTIVATED STATE OF THE 5-HYDROXYTRYPTAMINE(2A) RECEPTOR BY SITE-DIRECTED MUTAGENESIS - INVERSE AGONIST ACTIVITY OF ANTIPSYCHOTIC-DRUGS
Ct. Egan et al., CREATION OF A CONSTITUTIVELY ACTIVATED STATE OF THE 5-HYDROXYTRYPTAMINE(2A) RECEPTOR BY SITE-DIRECTED MUTAGENESIS - INVERSE AGONIST ACTIVITY OF ANTIPSYCHOTIC-DRUGS, The Journal of pharmacology and experimental therapeutics, 286(1), 1998, pp. 85-90
Single amino acid mutations in the third intracellular loop, as well a
s other domains of G protein-coupled receptors, have been shown to con
fer drastic changes in receptor properties and have been postulated to
be responsible for various disease states. To determine whether an am
ino acid mutation can confer dramatic alterations in the 5-hydroxytryp
tamine(2A) (5HT(2A)) receptor, we mutated amino acid 322 to lysine (C3
22K), glutamate (C322E) or arginine (C322R). Transient expression of t
he mutant receptors revealed properties associated with constitutive a
ctivity. Radioligand binding studies revealed an increase in 5-HT affi
nity from 293 nM (native) to 86 nM (C322E), 25 nM (C322K) and 11 nM (C
322R). 5-HT potency for stimulation of inositol phosphate production i
ncreased from 152 nM (native) to 61 nM (C322E) and 25 nM (C322K). Basa
l inositol phosphate levels in COS-7 cells expressing C322K and C322E
mutant receptors were 8-fold and 4-fold higher, respectively, than cel
ls expressing native 5-HT2A receptors. Basal levels of inositol phosph
ate stimulated by C322K receptors represented 48% of total inositol ph
osphate production stimulated by native receptors in the presence of 1
0 mu M 5-HT. Antipsychotic drugs (chlorpromazine, clozapine, haloperid
ol, loxapine and risperidone) displayed inverse agonist activity by in
hibiting C322K constitutive activation of phosphatidylinositol hydroly
sis. These data indicate that amino acid 322 in the 5-HT2A receptor pl
ays an important role in maintaining the inactive conformation and pro
vide further evidence that amino acid mutations can produce profound a
lterations in G protein-coupled receptor activity.